Michigan approves ban on antidepressant tianeptine sodium

April 6, 2018

Michigan's governor has signed what's been described by state police as the nation's first statewide ban on the antidepressant tianeptine sodium.

The office of Republican Gov. Rick Snyder announced Thursday that he signed the measure to classify the as a Schedule II controlled substance, placing it in the same highly restrictive category that cocaine and fall under.

State police flagged the drug to a state lawmaker after a spate of gruesome overdoses in the Midland and Saginaw area in 2017.

Tianeptine sodium is an atypical antidepressant that is not approved by the Food and Drug Administration. It is marketed as a supplement or research chemical through unregulated vendors but is often abused in high doses to simulate opioid-like highs.

Explore further: FDA panel votes for tougher restrictions on hydrocodone

Related Stories

FDA panel votes for tougher restrictions on hydrocodone

January 26, 2013
(HealthDay)—A U.S. Food and Drug Administration advisory panel met Thursday and Friday to discuss the fate of certain painkillers that contain the opioid known as hydrocodone, concluding in a vote in favor of moving hydrocodone ...

Strategies implemented to cut opioid ODs, deaths in maryland

June 15, 2017
(HealthDay)—Strategies are being implemented to reduce opioid overdoses and deaths in Maryland, according to a report published by the American Medical Association (AMA).

Opioid overdoses in ERs up 30 percent as crisis worsens

March 6, 2018
Emergency rooms saw a big jump in overdoses from opioids last year—the latest evidence the nation's drug crisis is getting worse.

New Mexico is 1st state to boost access to overdose antidote

April 6, 2017
New Mexico is the first state to require all local and state law enforcement agencies to provide officers with antidote kits as the state works to curb deaths from opioid and heroin overdoses.

Police try out new database for documenting opioid overdoses

August 14, 2017
Police in Massachusetts are testing a new database for documenting opioid overdoses they hope will help departments share information in real time and get people into treatment.

States ask insurers to prioritize non-opioid pain treatment

September 18, 2017
Attorneys general representing the majority of states are asking the insurance industry to encourage pain treatment through means other than prescriptions for opioid painkillers.

Recommended for you

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

Opioid prescriptions from dentists linked to youth addiction risk

December 3, 2018
Teens and young adults who receive their initial opioid prescriptions from their dentists or oral surgeons are at increased risk for opioid addiction in the following year, a study from the Stanford University School of Medicine ...

Rise in meth and opioid use during pregnancy

November 29, 2018
Amphetamine and opioid use in pregnancy increased substantially over the last decade in the United States, a new Michigan Medicine-led study finds. And a disproportionate rise occurred in rural counties.

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

oliverlu70
not rated yet Apr 07, 2018
How many is a "spate"? Tianeptine is not even sold in English-speaking countries as far as I'm aware.

Perhaps Big Pharma was threatened by the existence of an SSRE? (selective serotonin reuptake enhancer--works the opposite of SSRIs, makes you question their hypothesis about low serotonin levels causing depression).

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.